TrueRelief, LLC

TrueRelief, LLC has raised $100K in total funding. The most recent round was Series A.

TrueRelief, LLC is headquartered in Santa Monica, CA.

TrueRelief is an FDA-cleared, non-invasive medical device that delivers an electroceutical treatment that uses a patented combination of high frequency electrical current delivered dynamically by a skilled medical professional. The treatment itself is completely painless.

Managing postoperative and chronic pain often relies on opioids, which carry side effects and dependency risk.

TrueRelief is a non-opioid, non-invasive neuromodulation device that clinicians use to treat acute and chronic pain as an alternative to opioid medication.

Uses a proprietary electrical configuration described as 20,000 Hz high frequency (versus 50-400 Hz for other electrical therapies) with pulsed direct current and dynamically directed stainless-steel probes rather than static electrodes; a cited sham-controlled clinical trial reported 47% lower opioid usage and patients 2.5x less likely to need a prescription at discharge, and the device is patent-protected.

TrueRelief's president, John Crosson, was the angel investor behind the underlying pain-relief technology, and co-founder Herminio Llevat previously founded True North Investments.